Randomized, double-blind, placebo-controlled phase II study of AMG 386 in combination with cisplatin and capecitabine (CX) in patients (pts) with metastatic gastroesophageal adenocarcinoma

dc.contributor.author	Valladares Ayerbes, Manuel
dc.date.accessioned	2017-06-07T07:07:11Z
dc.date.available	2017-06-07T07:07:11Z
dc.date.issued	2011
dc.identifier.issn	1556-0864
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2819
dc.language.iso	eng
dc.title	Randomized, double-blind, placebo-controlled phase II study of AMG 386 in combination with cisplatin and capecitabine (CX) in patients (pts) with metastatic gastroesophageal adenocarcinoma
dc.type	Publicación de congreso
dc.authorsophos	Eatock, M. M.
dc.authorsophos	Szanto, J.
dc.authorsophos	Tebbutt, N. C.
dc.authorsophos	Bampton, C. L.
dc.authorsophos	Strickland, A. H.
dc.authorsophos	Valladares Ayerbes, M.
dc.authorsophos	Nanayakkara, N.
dc.authorsophos	Sun, Y.
dc.authorsophos	Adewoye, A. H.
dc.authorsophos	Bodoky, G.
dc.identifier.sophos	9093
dc.issue.number	suppl 4
dc.journal.title	Journal of Thoracic Oncology
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	6

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.